Authors
Jagsi, ReshmaChadha, Manjeet
Moni, Janaki
Ballman, Karla
Laurie, Fran
Buchholz, Thomas A.
Giuliano, Armando
Haffty, Bruce G.
Document Type
Journal ArticlePublication Date
2014-11-10
Metadata
Show full item recordAbstract
PURPOSE: ACOSOG Z0011 established that axillary lymph node dissection (ALND) is unnecessary in patients with breast cancer with one to two positive sentinel lymph nodes (SLNs) who undergo lumpectomy, radiotherapy (RT), and systemic therapy. We sought to ascertain RT coverage of the regional nodes in that trial. METHODS: We evaluated case report forms completed 18 months after enrollment. From 2012 to 2013, we collected all available detailed RT records for central review. RESULTS: Among 605 patients with completed case report forms, 89% received whole-breast RT. Of these, 89 (15%) were recorded as also receiving treatment to the supraclavicular region. Detailed RT records were obtained for 228 patients, of whom 185 (81.1%) received tangent-only treatment. Among 142 with sufficient records to evaluate tangent height, high tangents (cranial tangent border /= three fields: 22 in the ALND arm and 21 in the SLND arm. Those receiving directed nodal RT had greater nodal involvement (P < .001) than those who did not. Overall, there was no significant difference between treatment arms in the use of protocol-prohibited nodal fields. CONCLUSION: Most patients treated in Z0011 received tangential RT alone, and some received no RT at all. Some patients received directed nodal irradiation via a third field. Further research is necessary to determine the optimal RT approach in patients with low-volume axillary disease treated with SLND alone.Source
J Clin Oncol. 2014 Nov 10;32(32):3600-6. doi: 10.1200/JCO.2014.56.5838. Epub 2014 Aug 18. Link to article on publisher's siteDOI
10.1200/JCO.2014.56.5838Permanent Link to this Item
http://hdl.handle.net/20.500.14038/46460PubMed ID
25135994Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1200/JCO.2014.56.5838